What percentage of UTHR is owned by institutions?

Based on Q1 2026 13F filings, institutional ownership of United Therapeutics Corporation stands at 105.0%, held across 824 reporting institutions.

Who is the largest institutional holder of UTHR?

BlackRock, Inc. is the largest reported institutional holder of UTHR, with approximately 5,399,649 shares worth $3.20B as of Q1 2026.

Is UTHR a hedge fund favorite?

Yes — 3 widely-followed marquee investors appear among the top 25 institutional holders of UTHR, including RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC.

What is UTHR's Smart Money Score?

Our composite Smart Money Score for UTHR is 72 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

How many institutions bought UTHR this quarter?

123 institutions opened new positions in UTHR during Q1 2026, while 108 fully exited. 577 added to existing positions and 121 trimmed.

How is institutional ownership of UTHR changing?

UTHR institutional ownership rose by 20.30 percentage points quarter-over-quarter, with a net change of +15 holders.

How concentrated is UTHR ownership among the top holders?

The top 10 institutions account for 51.6% of all reported 13F value in UTHR, and the top 25 account for 70.3%.

Where does this UTHR institutional ownership data come from?

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.

United Therapeutics Corporation (UTHR) Institutional Ownership Q1 2026 | Top 13F Holders

VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

← Back to Screener

United Therapeutics Corporation (UTHR) Institutional Ownership Q1 2026 | Top 13F Holders | VCP Scanner

Top Institutional Holders of UTHR

Ranked by reported Q1 2026 13F market value

Top 10 Holders

51.6%

Top 25 Holders

70.3%

Share of total reported institutional value in UTHR held by the largest 10 / 25 filers.

#	Institution	Shares Held	Market Value	QoQ Change	Ownership %	% of Fund
1	BlackRock, Inc.	5.4M	$3.20B	+4.4%	12.721%	0.06%
2	Avoro Capital Advisors LLC	3.0M	$1.57B	+15.5%	7.091%	16.06%
3	WELLINGTON MANAGEMENT GROUP LLP	2.3M	$1.34B	-7.3%	5.334%	0.25%
4	VANGUARD PORTFOLIO MANAGEMENT LLC	2.0M	$1.19B	—	4.721%	0.06%
5	VANGUARD CAPITAL MANAGEMENT LLC	2.0M	$1.16B	—	4.612%	0.03%
6	STATE STREET CORP	1.8M	$1.09B	+0.1%	4.344%	0.04%
7	RENAISSANCE TECHNOLOGIES LLC	1.8M	$1.06B	-6.4%	4.210%	1.66%
8	GEODE CAPITAL MANAGEMENT, LLC	1.2M	$729.9M	+3.4%	2.905%	0.05%
9	Caption Management, LLC	1.2M	$682.9M	—	2.713%	6.53%
10	JANUS HENDERSON GROUP PLC	867K	$514.0M	+8.9%	2.042%	0.25%
11	SUSQUEHANNA INTERNATIONAL GROUP, LLP	862K	$511.4M	+72.0%	2.032%	0.06%
12	AQR CAPITAL MANAGEMENT LLC	826K	$486.4M	-35.5%	1.946%	0.22%
13	CITADEL ADVISORS LLC	698K	$413.8M	+128.3%	1.644%	0.19%
14	ASSETMARK, INC	616K	$365.3M	-3.0%	1.451%	0.74%
15	Invesco Ltd.	608K	$360.7M	-0.1%	1.433%	0.06%
16	FMR LLC	528K	$313.3M	+30.8%	1.245%	0.02%
17	DIMENSIONAL FUND ADVISORS LP	513K	$304.0M	-2.9%	1.208%	0.06%
18	DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	457K	$271.0M	+7.3%	1.077%	3.20%
19	NORTHERN TRUST CORP	437K	$258.9M	+4.3%	1.028%	0.03%
20	BAILLIE GIFFORD & CO	428K	$253.9M	+32.5%	1.009%	0.26%
21	MORGAN STANLEY	409K	$242.7M	+5.1%	0.964%	0.01%
22	CAISSE DE DEPOT ET PLACEMENT DU QUEBEC	344K	$203.8M	+16.0%	0.810%	0.33%
23	Bank of New York Mellon Corp	329K	$195.2M	-1.3%	0.775%	0.04%
24	Swedbank AB	327K	$194.0M	+0.7%	0.771%	0.20%
25	Pictet Asset Management Holding SA	309K	$183.3M	+0.8%	0.728%	0.20%

denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in UTHR — a direct measure of their conviction.

UTHR Institutional Ownership by Quarter

8 quarters of 13F filings · Δ columns show change vs prior quarter

Quarter	Inst. Holders	Δ Holders	Ownership %	Δ Ownership	Total 13F Value	Δ Value
Q1 2026	824	+1.9%	104.98%	+20.30 pp	$24.33B	+24%
Q4 2025	809	+19%	84.68%	+11.54 pp	$19.62B	+16%
Q3 2025	679	+4.1%	73.14%	+21.65 pp	$16.95B	+42%
Q2 2025	652	+0.9%	51.49%	2.74 pp	$11.93B	5.1%
Q1 2025	646	0.6%	54.23%	8.22 pp	$12.57B	13%
Q4 2024	650	+8.2%	62.45%	0.10 pp	$14.47B	0.2%
Q3 2024	601	+9.5%	62.55%	+3.74 pp	$14.49B	+6.4%
Q2 2024	549	—	58.81%	—	$13.63B	—

Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.

United Therapeutics Corporation (UTHR) Institutional Ownership

AI Insights & Key Takeaways

Top Institutional Holders of UTHR

Quarterly Institutional Activity

New Buyers

Exited Positions

UTHR Institutional Ownership by Quarter

UTHR — Frequently Asked Questions